FDA inspection
Lilly del Caribe, Inc: FDA inspection ending Feb 16, 2024
FDA inspection 1232628 · Voluntary Action Indicated (VAI) · Carolina, PR
Key facts
| Inspection ID | 1232628 |
|---|---|
| Firm | Lilly del Caribe, Inc |
| FEI number | 2619243 |
| Address | 12.6 Km 65th Infantry Road (Pr01) |
| City | Carolina |
| State | PR |
| ZIP | 00985 |
| Fiscal year | 2024 |
| Inspection end date | Feb 16, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data